Testing effectiveness (Phase 2)Ended earlyNCT02685111
What this trial is testing
Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
Who this might be right for
Breast CancerNeutropeniaFebrile Neutropenia
Asan Medical Center 22